Vykat XR will be available in April to treat the intense hunger that is a hallmark of the rare genetic disease Prader-Willi ...

Diazoxide 50mg/mL; chocolate-mint flavor; contains alcohol 7.25%. Diazoxide administered orally produces a prompt dose-related increase in blood glucose level, due primarily to an inhibition of ...

Diazoxide choline is the first drug indicated for hyperphagia in the rare genetic disorder. Prior to approval, people with Prader-Willi had to rely on strict dieting and off-label obesity medications.

Shares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR (diazoxide choline ... expects to launch the drug in the United States ...